Variant report

Variant	esv1843898
Chromosome Location	chr16:31961450-32375661
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:3444)
CpG islands
(count:3544)
Chromatin interactive
region (count:1)
LncRNA
region (count:13)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:3444 , 50 per page) page: 1 2 3 4 5 6 7 ... 69

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:32131861-32132041	HepG2	liver:	n/a	n/a
2	ARID3A	chr16:32345726-32345816	HepG2	liver:	n/a	n/a
3	ARID3A	chr16:32295698-32295892	HepG2	liver:	n/a	n/a
4	ATF1	chr16:32363593-32363793	K562	blood:	n/a	n/a
5	ATF1	chr16:32194699-32194908	K562	blood:	n/a	n/a
6	BATF	chr16:32144482-32144672	GM12878	blood:	n/a	n/a
7	BATF	chr16:32100565-32100763	GM12878	blood:	n/a	n/a
8	BATF	chr16:32102770-32103216	GM12878	blood:	n/a	n/a
9	BATF	chr16:32361068-32361342	GM12878	blood:	n/a	n/a
10	BATF	chr16:32099644-32100206	GM12878	blood:	n/a	n/a
11	BATF	chr16:32108354-32108543	GM12878	blood:	n/a	n/a
12	BATF	chr16:32333643-32333817	GM12878	blood:	n/a	n/a
13	BATF	chr16:32139079-32139319	GM12878	blood:	n/a	n/a
14	BATF	chr16:32001426-32001621	GM12878	blood:	n/a	n/a
15	BATF	chr16:32108268-32108476	GM12878	blood:	n/a	n/a
16	BATF	chr16:32098574-32098849	GM12878	blood:	n/a	n/a
17	BATF	chr16:32105349-32105637	GM12878	blood:	n/a	n/a
18	BATF	chr16:32368458-32368823	GM12878	blood:	n/a	n/a
19	BATF	chr16:32335083-32335294	GM12878	blood:	n/a	n/a
20	BATF	chr16:32133244-32133444	GM12878	blood:	n/a	n/a
21	BATF	chr16:32099023-32099501	GM12878	blood:	n/a	n/a
22	BATF	chr16:32101215-32101624	GM12878	blood:	n/a	chr16:32101437-32101448
23	BATF	chr16:32373029-32373235	GM12878	blood:	n/a	n/a
24	BATF	chr16:32144456-32144674	GM12878	blood:	n/a	n/a
25	BATF	chr16:32133941-32134130	GM12878	blood:	n/a	n/a
26	BATF	chr16:32059227-32059446	GM12878	blood:	n/a	n/a
27	BATF	chr16:32150053-32150293	GM12878	blood:	n/a	n/a
28	BATF	chr16:32101090-32101595	GM12878	blood:	n/a	chr16:32101437-32101448
29	BATF	chr16:32050371-32050791	GM12878	blood:	n/a	n/a
30	BATF	chr16:32102790-32103063	GM12878	blood:	n/a	n/a
31	BATF	chr16:31967621-31968011	GM12878	blood:	n/a	n/a
32	BATF	chr16:32368414-32368848	GM12878	blood:	n/a	n/a
33	BATF	chr16:32335047-32335307	GM12878	blood:	n/a	n/a
34	BATF	chr16:32007628-32007992	GM12878	blood:	n/a	n/a
35	BATF	chr16:32094016-32094261	GM12878	blood:	n/a	chr16:32094090-32094099
36	BATF	chr16:32148154-32148425	GM12878	blood:	n/a	n/a
37	BATF	chr16:32099142-32100510	GM12878	blood:	n/a	n/a
38	BATF	chr16:32059238-32059578	GM12878	blood:	n/a	n/a
39	BATF	chr16:32366962-32367454	GM12878	blood:	n/a	chr16:32367243-32367254
40	BATF	chr16:32140974-32141195	GM12878	blood:	n/a	n/a
41	BCL11A	chr16:32108319-32108554	GM12878	blood:	n/a	n/a
42	BCL11A	chr16:32145107-32145410	GM12878	blood:	n/a	n/a
43	BCL11A	chr16:32324188-32324427	GM12878	blood:	n/a	n/a
44	BCL11A	chr16:32146932-32147161	GM12878	blood:	n/a	n/a
45	BCL11A	chr16:32103295-32103464	GM12878	blood:	n/a	n/a
46	BCL11A	chr16:32105603-32105910	GM12878	blood:	n/a	n/a
47	BCL11A	chr16:32099658-32100165	GM12878	blood:	n/a	n/a
48	BCL11A	chr16:32001120-32001954	GM12878	blood:	n/a	n/a
49	BCL11A	chr16:32148075-32148453	GM12878	blood:	n/a	n/a
50	BCL11A	chr16:32368660-32368862	GM12878	blood:	n/a	n/a

(count:3544 , 50 per page) page: 1 2 3 4 5 6 7 ... 71

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:32127313-32127363	HRE	kidney:	n/a
2	chr16:32355981-32356031	Hepatocyte	liver:	n/a
3	chr16:32165225-32165275	HRE	kidney:	n/a
4	chr16:32165196-32165246	HAEpiC	amniotic membrane:	n/a
5	chr16:32359756-32359806	SKMC	muscle:	n/a
6	chr16:32363978-32364028	HepG2	liver:	n/a
7	chr16:32127313-32127363	HRE	kidney:	n/a
8	chr16:32355981-32356031	Hepatocyte	liver:	n/a
9	chr16:32165225-32165275	HRE	kidney:	n/a
10	chr16:32165196-32165246	HAEpiC	amniotic membrane:	n/a
11	chr16:32359756-32359806	SKMC	muscle:	n/a
12	chr16:32363978-32364028	HepG2	liver:	n/a
13	chr16:32330302-32330352	IMR90	lung:	fetal
14	chr16:32252787-32252837	Hepatocyte	liver:	n/a
15	chr16:31993231-31993281	AoSMC	blood vessel:	n/a
16	chr16:32127659-32127709	U87	brain:	n/a
17	chr16:32165225-32165275	AG09319	gingival:	n/a
18	chr16:32362057-32362107	T-47D	breast:	n/a
19	chr16:31995423-31995473	MCF-7	breast:	n/a
20	chr16:32123983-32124033	MCF10A-Er-Src	breast:	n/a
21	chr16:32330302-32330352	NT2-D1	testis:	n/a
22	chr16:32214185-32214235	HRCEpiC	kidney:	n/a
23	chr16:32265041-32265091	A549	lung:	n/a
24	chr16:32252365-32252415	SK-N-SH_RA	brain:	n/a
25	chr16:32265041-32265091	Hepatocyte	liver:	n/a
26	chr16:32322028-32322078	NB4	blood:	n/a
27	chr16:32201912-32201962	GM12892	blood:	n/a
28	chr16:32123983-32124033	SKMC	muscle:	n/a
29	chr16:32254800-32254850	HRCEpiC	kidney:	n/a
30	chr16:32127313-32127363	MCF-7	breast:	n/a
31	chr16:32360428-32360478	PANC-1	pancreas:	n/a
32	chr16:32201912-32201962	HL-60	blood:	n/a
33	chr16:32290371-32290421	HRCEpiC	kidney:	n/a
34	chr16:32289928-32289978	PANC-1	pancreas:	n/a
35	chr16:32165196-32165246	Jurkat	blood:	n/a
36	chr16:32130303-32130353	HRCEpiC	kidney:	n/a
37	chr16:32265747-32265797	HCF	heart:	n/a
38	chr16:32201912-32201962	HUVEC	blood vessel:	n/a
39	chr16:32252365-32252415	T-47D	breast:	n/a
40	chr16:32037687-32037737	GM12878	blood:	n/a
41	chr16:31993479-31993529	HPAEpiC	pulmonary alveolar:	n/a
42	chr16:32213913-32213963	AG09319	gingival:	n/a
43	chr16:32290466-32290516	Caco-2	colon:	n/a
44	chr16:32213913-32213963	SK-N-SH_RA	brain:	n/a
45	chr16:32213944-32213994	ovcar-3	ovarian:	n/a
46	chr16:32130303-32130353	GM06990	blood:	n/a
47	chr16:32165153-32165203	Jurkat	blood:	n/a
48	chr16:32359673-32359723	AG09309	skin:	n/a
49	chr16:32288799-32288849	NHDF-neo	bronchial:	n/a
50	chr16:31995423-31995473	HEEpiC	esophagus:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:106598214..106598843-chr16:32050606..32051126,2	MCF-7	breast:

(count:13 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC133485.1.1-1	chr16:32204071-32204851	ENSG00000260847.1
2	lnc-TP53TG3-3	chr16:32334099-32334218	XLOC_011921
3	lnc-ZNF267-4	chr16:31972893-31972899	NONHSAT141979
4	lnc-TP53TG3-4	chr16:32275068-32275108	ENSG00000260402.1
5	lnc-AC133485.1.1-1	chr16:32199654-32199738	ENSG00000260847.1
6	lnc-ZNF267-4	chr16:31975124-31975400	NONHSAT141983
7	lnc-TP53TG3-4	chr16:32274229-32274612	ENSG00000260402.1
8	lnc-ZNF267-4	chr16:31973257-31973743	NONHSAT141979
9	lnc-TP53TG3-7	chr16:32265674-32265743	ENSG00000260575.1
10	lnc-ZNF267-3	chr16:31963481-31963794	NONHSAT141978
11	lnc-AC133485.1.1-7	chr16:32200583-32200802	NONHSAT141994
12	lnc-TP53TG3-3	chr16:32335100-32335382	XLOC_011921
13	lnc-TP53TG3-7	chr16:32261941-32262132	ENSG00000260575.1

No data

Variant related genes	Relation type
ENSG00000260540	TF binding region
ENSG00000260402	TF binding region
ENSG00000260575	TF binding region
ENSG00000259822	TF binding region
HERC2P4	TF binding region
ENSG00000261289	TF binding region
ENSG00000223931	TF binding region
ENSG00000260628	TF binding region
ENSG00000260344	TF binding region
TP53TG3D	TF binding region
ENSG00000260584	TF binding region
ENSG00000261127	TF binding region
ENSG00000197476	TF binding region
IGHV1OR16-1	TF binding region
ENSG00000260649	TF binding region
IGHV3OR16-9	TF binding region
ENSG00000260218	TF binding region
ENSG00000260847	TF binding region
ENSG00000261727	TF binding region
IGHV1OR16-3	TF binding region
ENSG00000260516	TF binding region
ENSG00000260540	CpG island
ENSG00000260402	CpG island
ENSG00000260575	CpG island
ENSG00000259822	CpG island
HERC2P4	CpG island
ENSG00000261289	CpG island
ENSG00000223931	CpG island
ENSG00000260628	CpG island
ENSG00000260344	CpG island
TP53TG3D	CpG island
ENSG00000260584	CpG island
ENSG00000261127	CpG island
ENSG00000197476	CpG island
IGHV1OR16-1	CpG island
ENSG00000260649	CpG island
IGHV3OR16-9	CpG island
ENSG00000260218	CpG island
ENSG00000260847	CpG island
ENSG00000261727	CpG island
IGHV1OR16-3	CpG island
ENSG00000260516	CpG island
LBR	miRNA target sites

Extended variants
information (count: 3622 )
Associated
traits (count: 132 )

Variant overlapped rSNPs/rCNVs (count:3622 , 50 per page) page: 1 2 3 4 5 6 7 ... 73

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs544541958	chr16:31962620-31962621	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs556062151	chr16:31962648-31962649	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs143601696	chr16:31962765-31962766	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs71376374	chr16:31962794-31962795	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs541911350	chr16:31962798-31962799	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs560309090	chr16:31962799-31962800	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs181905615	chr16:31962807-31962808	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs2659718	chr16:31962859-31962860	Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs370272914	chr16:31962878-31962879	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs2519306	chr16:31962888-31962889	Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs372603278	chr16:31962897-31962898	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs142885937	chr16:31962952-31962953	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs55968411	chr16:31963043-31963044	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs531911677	chr16:31963109-31963110	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs200604839	chr16:31963111-31963112	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs568546966	chr16:31963202-31963203	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs538591538	chr16:31963206-31963207	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs547460093	chr16:31963286-31963287	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs565839973	chr16:31963322-31963323	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs539408095	chr16:31963343-31963344	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs115330180	chr16:31963374-31963375	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs370389197	chr16:31963433-31963434	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs537732652	chr16:31963450-31963451	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs556435539	chr16:31963500-31963501	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
25	rs574516874	chr16:31963542-31963543	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
26	rs535647137	chr16:31963573-31963574	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
27	rs553860502	chr16:31963598-31963599	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
28	rs572159491	chr16:31963681-31963682	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
29	rs545964612	chr16:31963682-31963683	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
30	rs563907341	chr16:31963719-31963720	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
31	rs139877814	chr16:31963770-31963771	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
32	rs576025150	chr16:31963786-31963787	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
33	rs543725950	chr16:31963802-31963803	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs562428169	chr16:31963856-31963857	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs529400774	chr16:31963893-31963894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs547594432	chr16:31963929-31963930	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs559561810	chr16:31963999-31964000	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs533230913	chr16:31964063-31964064	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs551885421	chr16:31964117-31964118	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs112143234	chr16:31964204-31964205	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs2661736	chr16:31964213-31964214	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs4107192	chr16:31964292-31964293	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs537473824	chr16:31964380-31964381	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs549760560	chr16:31964392-31964393	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs7500857	chr16:31971070-31971071	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs7500861	chr16:31971086-31971087	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs113145928	chr16:31971135-31971136	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs369781302	chr16:31971179-31971180	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs201495592	chr16:31971198-31971199	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs182563267	chr16:31971220-31971221	Inactive region	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:132)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Sezary syndrome	18413736	CNVD
Wilms tumour	21544195	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164920	CNVD
Autism	19287141	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	20967226	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Melanoma	20877625	CNVD
Breast cancer	17142309	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:346 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:31962600-31963000	Enhancers	Primary T killer memory cells from peripheral blood	blood
2	chr16:31962600-31963400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
3	chr16:31962800-31963400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
4	chr16:31962800-31963600	Enhancers	Primary T cells fromperipheralblood	blood
5	chr16:31962800-31963600	Enhancers	Primary T helper cells PMA-I stimulated	--
6	chr16:31963200-31963400	Enhancers	Primary T helper naive cells from peripheral blood	blood
7	chr16:31963200-31964000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
8	chr16:31963600-31964200	Weak transcription	Primary T helper cells PMA-I stimulated	--
9	chr16:31964200-31964400	Enhancers	Primary T helper naive cells from peripheral blood	blood
10	chr16:31964200-31964400	Enhancers	Primary T helper cells PMA-I stimulated	--
11	chr16:31971800-31972200	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr16:32002400-32002800	Enhancers	HepG2	liver
13	chr16:32051200-32051600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
14	chr16:32051400-32051600	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr16:32051400-32051600	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr16:32077600-32078000	Enhancers	Dnd41	blood
17	chr16:32095200-32095400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
18	chr16:32095400-32096400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
19	chr16:32096000-32096200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
20	chr16:32096000-32096200	Active TSS	Primary T regulatory cells fromperipheralblood	blood
21	chr16:32096200-32096400	Flanking Bivalent TSS/Enh	Primary B cells from peripheral blood	blood
22	chr16:32096200-32096400	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
23	chr16:32096200-32096400	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
24	chr16:32096200-32096600	Flanking Bivalent TSS/Enh	Placenta	Placenta
25	chr16:32096200-32096800	Active TSS	Primary T helper cells fromperipheralblood	blood
26	chr16:32096200-32096800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr16:32096200-32097000	Bivalent/Poised TSS	Primary T helper cells PMA-I stimulated	--
28	chr16:32096200-32097200	Active TSS	Primary T cells from cord blood	blood
29	chr16:32096200-32097200	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
30	chr16:32096200-32097200	Active TSS	Primary T helper naive cells fromperipheralblood	blood
31	chr16:32096200-32097200	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
32	chr16:32096200-32097200	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
33	chr16:32096200-32097400	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
34	chr16:32096200-32097400	Active TSS	Right Atrium	heart
35	chr16:32096200-32097400	Bivalent/Poised TSS	A549	lung
36	chr16:32096200-32097400	Active TSS	Osteobl	bone
37	chr16:32096400-32096600	Flanking Bivalent TSS/Enh	Primary monocytes fromperipheralblood	blood
38	chr16:32096400-32096600	Flanking Bivalent TSS/Enh	Primary Natural Killer cells fromperipheralblood	blood
39	chr16:32096400-32096600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
40	chr16:32096400-32096800	Bivalent/Poised TSS	Primary B cells from peripheral blood	blood
41	chr16:32096400-32096800	ZNF genes & repeats	Primary hematopoietic stem cells short term culture	blood
42	chr16:32096400-32096800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr16:32096400-32096800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
44	chr16:32096400-32096800	ZNF genes & repeats	Right Ventricle	heart
45	chr16:32096400-32096800	Active TSS	HSMM	muscle
46	chr16:32096400-32097000	Bivalent Enhancer	Fetal Muscle Leg	muscle
47	chr16:32096400-32097200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr16:32096400-32097200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr16:32096400-32097200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr16:32096400-32097200	Active TSS	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links